Lu-Xiu Yang

531 total citations · 1 hit paper
8 papers, 394 citations indexed

About

Lu-Xiu Yang is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Lu-Xiu Yang has authored 8 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Physiology. Recurrent topics in Lu-Xiu Yang's work include Autophagy in Disease and Therapy (3 papers), Alzheimer's disease research and treatments (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Lu-Xiu Yang is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Alzheimer's disease research and treatments (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Lu-Xiu Yang collaborates with scholars based in China and Hong Kong. Lu-Xiu Yang's co-authors include Yong‐Gang Yao, Rongcan Luo, Qianjin Liu, Ling‐Yan Su, Yu Fan, Jing Yang, Min Xu, Dengfeng Zhang, Jiali Li and Hejiang Zhou and has published in prestigious journals such as Free Radical Biology and Medicine, Signal Transduction and Targeted Therapy and Autophagy.

In The Last Decade

Lu-Xiu Yang

7 papers receiving 393 citations

Hit Papers

Activation of PPARA-mediated autophagy reduces Alzheimer ... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu-Xiu Yang China 5 175 135 133 82 62 8 394
Zhimin Long China 14 300 1.7× 221 1.6× 118 0.9× 54 0.7× 58 0.9× 21 596
M O Kim South Korea 9 209 1.2× 135 1.0× 85 0.6× 69 0.8× 38 0.6× 9 521
Myung‐Hee Moon South Korea 13 370 2.1× 155 1.1× 157 1.2× 71 0.9× 37 0.6× 18 610
Magdalena Dudkowska Poland 9 247 1.4× 149 1.1× 58 0.4× 92 1.1× 40 0.6× 21 513
James Peddy United States 3 171 1.0× 280 2.1× 136 1.0× 77 0.9× 61 1.0× 6 485
Yu Young Jeong United States 8 301 1.7× 274 2.0× 223 1.7× 68 0.8× 60 1.0× 11 586
Jiezhong Yu China 7 161 0.9× 119 0.9× 74 0.6× 146 1.8× 24 0.4× 16 386
Aida Adlimoghaddam Canada 9 148 0.8× 123 0.9× 49 0.4× 52 0.6× 40 0.6× 12 357
Meiling Xia China 4 229 1.3× 76 0.6× 107 0.8× 152 1.9× 40 0.6× 6 483

Countries citing papers authored by Lu-Xiu Yang

Since Specialization
Citations

This map shows the geographic impact of Lu-Xiu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu-Xiu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu-Xiu Yang more than expected).

Fields of papers citing papers by Lu-Xiu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu-Xiu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu-Xiu Yang. The network helps show where Lu-Xiu Yang may publish in the future.

Co-authorship network of co-authors of Lu-Xiu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lu-Xiu Yang. A scholar is included among the top collaborators of Lu-Xiu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu-Xiu Yang. Lu-Xiu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Xu, Ling, Dandan Yu, Yamin Liu, et al.. (2024). Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. EBioMedicine. 107. 105281–105281.
2.
Liu, Qianjin, et al.. (2024). GSNOR negatively regulates the NLRP3 inflammasome via S-nitrosation of MAPK14. Cellular and Molecular Immunology. 21(6). 561–574. 4 indexed citations
3.
Su, Ling‐Yan, Qianjin Liu, Xinhua Qiao, et al.. (2024). S-nitrosoglutathione reductase alleviates morphine analgesic tolerance by restricting PKCα S-nitrosation. Redox Biology. 75. 103239–103239. 3 indexed citations
4.
Su, Ling‐Yan, Qianjin Liu, Rongcan Luo, et al.. (2022). GSNOR deficiency attenuates MPTP-induced neurotoxicity and autophagy by facilitating CDK5 S-nitrosation in a mouse model of Parkinson's disease. Free Radical Biology and Medicine. 189. 111–121. 9 indexed citations
5.
Liu, Qianjin, Ling‐Yan Su, Xinhua Qiao, et al.. (2021). GSNOR facilitates antiviral innate immunity by restricting TBK1 cysteine S-nitrosation. Redox Biology. 47. 102172–102172. 15 indexed citations
6.
Luo, Rongcan, Yu Fan, Jing Yang, et al.. (2021). A novel missense variant in ACAA1 contributes to early-onset Alzheimer’s disease, impairs lysosomal function, and facilitates amyloid-β pathology and cognitive decline. Signal Transduction and Targeted Therapy. 6(1). 325–325. 29 indexed citations
7.
Luo, Rongcan, Ling‐Yan Su, Guiyu Li, et al.. (2019). Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model. Autophagy. 16(1). 52–69. 274 indexed citations breakdown →
8.
Su, Ling‐Yan, Rongcan Luo, Qianjin Liu, et al.. (2017). Atg5 - and Atg7 -dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine. Autophagy. 13(9). 1496–1511. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026